Global Swine Reproductive and Respiratory Syndrome Vaccine Market Growth 2020-2025
According to this study, over the next five years the Swine Reproductive and Respiratory Syndrome Vaccine market will register a 10.6%% CAGR in terms of revenue, the global market size will reach $ 507.5 million by 2025, from $ 339.4 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Swine Reproductive and Respiratory Syndrome Vaccine business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Swine Reproductive and Respiratory Syndrome Vaccine market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Swine Reproductive and Respiratory Syndrome Vaccine, covering the supply chain analysis, impact assessment to the Swine Reproductive and Respiratory Syndrome Vaccine market size growth rate in several scenarios, and the measures to be undertaken by Swine Reproductive and Respiratory Syndrome Vaccine companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Active Vaccine
Inactivated Vaccines
The segment of active vaccine holds a comparatively larger share in global market, which accounts for about 90%.
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Government Tender
Market Sales
The vaccine is fully applicated in market sales.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
ASCENT CORPORATION
CAVAC
Boehringer-Ingelheim
SPAH
Ceva
MSD Animal Health
QILU ANIMAL HEALTH PRODUCTS CO.,LTD
Chengdu TECH-BANK Biological Products Co,.Ltd
DAHUANONG
ringpu
ANHUI TIANKANG(GROUP)SHRES O., LTD
WINSUN BIO
Zoetis
Komipharm
JINYU BIO-TECNOLOGY CO.,LTD
Bioveta
Phibro Animal Health
Agrovet
PULIKE BIOLOGICAL ENGINERING,INC.
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Swine Reproductive and Respiratory Syndrome Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Swine Reproductive and Respiratory Syndrome Vaccine market by identifying its various subsegments.
Focuses on the key global Swine Reproductive and Respiratory Syndrome Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Swine Reproductive and Respiratory Syndrome Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Swine Reproductive and Respiratory Syndrome Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2015-2025
2.1.2 Swine Reproductive and Respiratory Syndrome Vaccine Consumption CAGR by Region
2.2 Swine Reproductive and Respiratory Syndrome Vaccine Segment by Type
2.2.1 Active Vaccine
2.2.2 Inactivated Vaccines
2.3 Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Type
2.3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Type (2015-2020)
2.3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Type (2015-2020)
2.4 Swine Reproductive and Respiratory Syndrome Vaccine Segment by Application
2.4.1 Government Tender
2.4.2 Market Sales
2.5 Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Application
2.5.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Type (2015-2020)
2.5.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Value and Market Share by Type (2015-2020)
2.5.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Type (2015-2020)
3 Global Swine Reproductive and Respiratory Syndrome Vaccine by Company
3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Company
3.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Company (2018-2020)
3.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Company (2018-2020)
3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Company
3.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Company (2018-2020)
3.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Company (2018-2020)
3.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Company
3.4 Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Swine Reproductive and Respiratory Syndrome Vaccine by Regions
4.1 Swine Reproductive and Respiratory Syndrome Vaccine by Regions
4.2 Americas Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth
4.3 APAC Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth
4.4 Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth
4.5 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth
5 Americas
5.1 Americas Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Countries
5.1.1 Americas Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Countries (2015-2020)
5.1.2 Americas Swine Reproductive and Respiratory Syndrome Vaccine Value by Countries (2015-2020)
5.2 Americas Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Type
5.3 Americas Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Regions
6.1.1 APAC Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Regions (2015-2020)
6.1.2 APAC Swine Reproductive and Respiratory Syndrome Vaccine Value by Regions (2015-2020)
6.2 APAC Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Type
6.3 APAC Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine by Countries
7.1.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Countries (2015-2020)
7.1.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Value by Countries (2015-2020)
7.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Type
7.3 Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine by Countries
8.1.1 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Value by Countries (2015-2020)
8.2 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Type
8.3 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Swine Reproductive and Respiratory Syndrome Vaccine Distributors
10.3 Swine Reproductive and Respiratory Syndrome Vaccine Customer
11 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Forecast
11.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Forecast (2021-2025)
11.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Forecast by Regions
11.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Forecast by Regions (2021-2025)
11.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Swine Reproductive and Respiratory Syndrome Vaccine Forecast by Type
11.8 Global Swine Reproductive and Respiratory Syndrome Vaccine Forecast by Application
12 Key Players Analysis
12.1 ASCENT CORPORATION
12.1.1 Company Information
12.1.2 Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.1.3 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 ASCENT CORPORATION Latest Developments
12.2 CAVAC
12.2.1 Company Information
12.2.2 Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.2.3 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 CAVAC Latest Developments
12.3 Boehringer-Ingelheim
12.3.1 Company Information
12.3.2 Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.3.3 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Boehringer-Ingelheim Latest Developments
12.4 SPAH
12.4.1 Company Information
12.4.2 Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.4.3 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 SPAH Latest Developments
12.5 Ceva
12.5.1 Company Information
12.5.2 Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.5.3 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Ceva Latest Developments
12.6 MSD Animal Health
12.6.1 Company Information
12.6.2 Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.6.3 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 MSD Animal Health Latest Developments
12.7 QILU ANIMAL HEALTH PRODUCTS CO.,LTD
12.7.1 Company Information
12.7.2 Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.7.3 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Latest Developments
12.8 Chengdu TECH-BANK Biological Products Co,.Ltd
12.8.1 Company Information
12.8.2 Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.8.3 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Chengdu TECH-BANK Biological Products Co,.Ltd Latest Developments
12.9 DAHUANONG
12.9.1 Company Information
12.9.2 Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.9.3 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 DAHUANONG Latest Developments
12.10 ringpu
12.10.1 Company Information
12.10.2 Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.10.3 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 ringpu Latest Developments
12.11 ANHUI TIANKANG(GROUP)SHRES O., LTD
12.11.1 Company Information
12.11.2 Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.11.3 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 ANHUI TIANKANG(GROUP)SHRES O., LTD Latest Developments
12.12 WINSUN BIO
12.12.1 Company Information
12.12.2 Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.12.3 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 WINSUN BIO Latest Developments
12.13 Zoetis
12.13.1 Company Information
12.13.2 Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.13.3 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Zoetis Latest Developments
12.14 Komipharm
12.14.1 Company Information
12.14.2 Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.14.3 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Komipharm Latest Developments
12.15 JINYU BIO-TECNOLOGY CO.,LTD
12.15.1 Company Information
12.15.2 Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.15.3 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 JINYU BIO-TECNOLOGY CO.,LTD Latest Developments
12.16 Bioveta
12.16.1 Company Information
12.16.2 Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.16.3 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Bioveta Latest Developments
12.17 Phibro Animal Health
12.17.1 Company Information
12.17.2 Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.17.3 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Phibro Animal Health Latest Developments
12.18 Agrovet
12.18.1 Company Information
12.18.2 Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.18.3 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Agrovet Latest Developments
12.19 PULIKE BIOLOGICAL ENGINERING,INC.
12.19.1 Company Information
12.19.2 Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.19.3 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 PULIKE BIOLOGICAL ENGINERING,INC. Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Swine Reproductive and Respiratory Syndrome Vaccine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Active Vaccine
Table 5. Major Players of Inactivated Vaccines
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Type (2015-2020)
Table 8. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2015-2020) ($ million)
Table 9. Global Swine Reproductive and Respiratory Syndrome Vaccine Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Application (2015-2020)
Table 13. Global Swine Reproductive and Respiratory Syndrome Vaccine Value by Application (2015-2020)
Table 14. Global Swine Reproductive and Respiratory Syndrome Vaccine Value Market Share by Application (2015-2020)
Table 15. Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Application (2015-2020)
Table 16. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Company (2017-2019) (K Units)
Table 17. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Company (2017-2019)
Table 18. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Company (2017-2019)
Table 20. Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Company (2017-2019)
Table 21. Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
Table 23. Swine Reproductive and Respiratory Syndrome Vaccine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Regions 2015-2020 (K Units)
Table 25. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Regions 2015-2020
Table 26. Global Swine Reproductive and Respiratory Syndrome Vaccine Value by Regions 2015-2020 ($ Millions)
Table 27. Global Swine Reproductive and Respiratory Syndrome Vaccine Value Market Share by Regions 2015-2020
Table 28. Americas Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Countries (2015-2020)
Table 30. Americas Swine Reproductive and Respiratory Syndrome Vaccine Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Swine Reproductive and Respiratory Syndrome Vaccine Value Market Share by Countries (2015-2020)
Table 32. Americas Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Type (2015-2020) (K Units)
Table 33. Americas Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Type (2015-2020)
Table 34. Americas Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Application (2015-2020) (K Units)
Table 35. Americas Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Application (2015-2020)
Table 36. APAC Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Countries (2015-2020) (K Units)
Table 37. APAC Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Countries (2015-2020)
Table 38. APAC Swine Reproductive and Respiratory Syndrome Vaccine Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Swine Reproductive and Respiratory Syndrome Vaccine Value Market Share by Regions (2015-2020)
Table 40. APAC Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Type (2015-2020) (K Units)
Table 41. APAC Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Type (2015-2020)
Table 42. APAC Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Application (2015-2020) (K Units)
Table 43. APAC Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Application (2015-2020)
Table 44. Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Countries (2015-2020)
Table 46. Europe Swine Reproductive and Respiratory Syndrome Vaccine Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Swine Reproductive and Respiratory Syndrome Vaccine Value Market Share by Countries (2015-2020)
Table 48. Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Type (2015-2020) (K Units)
Table 49. Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Type (2015-2020)
Table 50. Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Application (2015-2020) (K Units)
Table 51. Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Application (2015-2020)
Table 60. Swine Reproductive and Respiratory Syndrome Vaccine Distributors List
Table 61. Swine Reproductive and Respiratory Syndrome Vaccine Customer List
Table 62. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Forecast by Regions
Table 64. Global Swine Reproductive and Respiratory Syndrome Vaccine Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Swine Reproductive and Respiratory Syndrome Vaccine Value Market Share Forecast by Regions
Table 66. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Swine Reproductive and Respiratory Syndrome Vaccine Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Swine Reproductive and Respiratory Syndrome Vaccine Value Market Share Forecast by Type (2021-2025)
Table 70. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Swine Reproductive and Respiratory Syndrome Vaccine Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Swine Reproductive and Respiratory Syndrome Vaccine Value Market Share Forecast by Application (2021-2025)
Table 74. ASCENT CORPORATION Product Offered
Table 75. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. ASCENT CORPORATION Main Business
Table 77. ASCENT CORPORATION Latest Developments
Table 78. ASCENT CORPORATION Basic Information, Company Total Revenue (in $ million), Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. CAVAC Product Offered
Table 80. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. CAVAC Main Business
Table 82. CAVAC Latest Developments
Table 83. CAVAC Basic Information, Company Total Revenue (in $ million), Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Boehringer-Ingelheim Product Offered
Table 85. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. Boehringer-Ingelheim Main Business
Table 87. Boehringer-Ingelheim Latest Developments
Table 88. Boehringer-Ingelheim Basic Information, Company Total Revenue (in $ million), Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. SPAH Product Offered
Table 90. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. SPAH Main Business
Table 92. SPAH Latest Developments
Table 93. SPAH Basic Information, Company Total Revenue (in $ million), Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Ceva Product Offered
Table 95. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. Ceva Main Business
Table 97. Ceva Latest Developments
Table 98. Ceva Basic Information, Company Total Revenue (in $ million), Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. MSD Animal Health Product Offered
Table 100. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. MSD Animal Health Main Business
Table 102. MSD Animal Health Latest Developments
Table 103. MSD Animal Health Basic Information, Company Total Revenue (in $ million), Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Product Offered
Table 105. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Basic Information, Company Total Revenue (in $ million), Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Main Business
Table 107. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Latest Developments
Table 108. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 109. Chengdu TECH-BANK Biological Products Co,.Ltd Product Offered
Table 110. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. Chengdu TECH-BANK Biological Products Co,.Ltd Main Business
Table 112. Chengdu TECH-BANK Biological Products Co,.Ltd Latest Developments
Table 113. Chengdu TECH-BANK Biological Products Co,.Ltd Basic Information, Company Total Revenue (in $ million), Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. DAHUANONG Product Offered
Table 115. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 116. DAHUANONG Main Business
Table 117. DAHUANONG Latest Developments
Table 118. DAHUANONG Basic Information, Company Total Revenue (in $ million), Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. ringpu Product Offered
Table 120. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 121. ringpu Main Business
Table 122. ringpu Latest Developments
Table 123. ringpu Basic Information, Company Total Revenue (in $ million), Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. ANHUI TIANKANG(GROUP)SHRES O., LTD Product Offered
Table 125. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 126. ANHUI TIANKANG(GROUP)SHRES O., LTD Main Business
Table 127. ANHUI TIANKANG(GROUP)SHRES O., LTD Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. ANHUI TIANKANG(GROUP)SHRES O., LTD Latest Developments
Table 129. WINSUN BIO Product Offered
Table 130. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 131. WINSUN BIO Main Business
Table 132. WINSUN BIO Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. WINSUN BIO Latest Developments
Table 134. Zoetis Product Offered
Table 135. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 136. Zoetis Main Business
Table 137. Zoetis Latest Developments
Table 138. Zoetis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Komipharm Product Offered
Table 140. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 141. Komipharm Main Business
Table 142. Komipharm Latest Developments
Table 143. Komipharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 144. JINYU BIO-TECNOLOGY CO.,LTD Product Offered
Table 145. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 146. JINYU BIO-TECNOLOGY CO.,LTD Main Business
Table 147. JINYU BIO-TECNOLOGY CO.,LTD Latest Developments
Table 148. JINYU BIO-TECNOLOGY CO.,LTD Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 149. Bioveta Product Offered
Table 150. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 151. Bioveta Main Business
Table 152. Bioveta Latest Developments
Table 153. Bioveta Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 154. Phibro Animal Health Product Offered
Table 155. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 156. Phibro Animal Health Main Business
Table 157. Phibro Animal Health Latest Developments
Table 158. Phibro Animal Health Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 159. Agrovet Product Offered
Table 160. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 161. Agrovet Main Business
Table 162. Agrovet Latest Developments
Table 163. Agrovet Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 164. PULIKE BIOLOGICAL ENGINERING,INC. Product Offered
Table 165. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 166. PULIKE BIOLOGICAL ENGINERING,INC. Main Business
Table 167. PULIKE BIOLOGICAL ENGINERING,INC. Latest Developments
Table 168. PULIKE BIOLOGICAL ENGINERING,INC. Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Swine Reproductive and Respiratory Syndrome Vaccine
Figure 2. Swine Reproductive and Respiratory Syndrome Vaccine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Swine Reproductive and Respiratory Syndrome Vaccine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Active Vaccine
Figure 7. Product Picture of Inactivated Vaccines
Figure 8. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Type (2015-2020)
Figure 9. Global Swine Reproductive and Respiratory Syndrome Vaccine Value Market Share by Type (2015-2020)
Figure 10. Swine Reproductive and Respiratory Syndrome Vaccine Consumed in Government Tender
Figure 11. Global Swine Reproductive and Respiratory Syndrome Vaccine Market: Government Tender (2015-2020) (K Units)
Figure 12. Global Swine Reproductive and Respiratory Syndrome Vaccine Market: Government Tender (2015-2020) ($ Millions)
Figure 13. Swine Reproductive and Respiratory Syndrome Vaccine Consumed in Market Sales
Figure 14. Global Swine Reproductive and Respiratory Syndrome Vaccine Market: Market Sales (2015-2020) (K Units)
Figure 15. Global Swine Reproductive and Respiratory Syndrome Vaccine Market: Market Sales (2015-2020) ($ Millions)
Figure 16. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Application (2015-2020)
Figure 17. Global Swine Reproductive and Respiratory Syndrome Vaccine Value Market Share by Application (2015-2020)
Figure 18. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Company in 2017
Figure 19. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Company in 2019
Figure 20. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Company in 2017
Figure 21. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Company in 2019
Figure 22. Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Company in 2019
Figure 23. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Regions 2015-2020
Figure 24. Global Swine Reproductive and Respiratory Syndrome Vaccine Value Market Share by Regions 2015-2020
Figure 25. Americas Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2015-2020 (K Units)
Figure 26. Americas Swine Reproductive and Respiratory Syndrome Vaccine Value 2015-2020 ($ Millions)
Figure 27. APAC Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2015-2020 (K Units)
Figure 28. APAC Swine Reproductive and Respiratory Syndrome Vaccine Value 2015-2020 ($ Millions)
Figure 29. Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2015-2020 (K Units)
Figure 30. Europe Swine Reproductive and Respiratory Syndrome Vaccine Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2015-2020 (K Units)
Figure 32. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Value 2015-2020 ($ Millions)
Figure 33. Americas Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Countries in 2019
Figure 34. Americas Swine Reproductive and Respiratory Syndrome Vaccine Value Market Share by Countries in 2019
Figure 35. Americas Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Type in 2019
Figure 36. Americas Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Application in 2019
Figure 37. United States Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth 2015-2020 (K Units)
Figure 38. United States Swine Reproductive and Respiratory Syndrome Vaccine Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth 2015-2020 (K Units)
Figure 40. Canada Swine Reproductive and Respiratory Syndrome Vaccine Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth 2015-2020 (K Units)
Figure 42. Mexico Swine Reproductive and Respiratory Syndrome Vaccine Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Countries in 2019
Figure 44. APAC Swine Reproductive and Respiratory Syndrome Vaccine Value Market Share by Regions in 2019
Figure 45. APAC Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Type in 2019
Figure 46. APAC Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Application in 2019
Figure 47. China Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth 2015-2020 (K Units)
Figure 48. China Swine Reproductive and Respiratory Syndrome Vaccine Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth 2015-2020 (K Units)
Figure 50. Japan Swine Reproductive and Respiratory Syndrome Vaccine Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth 2015-2020 (K Units)
Figure 52. Korea Swine Reproductive and Respiratory Syndrome Vaccine Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth 2015-2020 (K Units)
Figure 54. Southeast Asia Swine Reproductive and Respiratory Syndrome Vaccine Value Growth 2015-2020 ($ Millions)
Figure 55. India Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth 2015-2020 (K Units)
Figure 56. India Swine Reproductive and Respiratory Syndrome Vaccine Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth 2015-2020 (K Units)
Figure 58. Australia Swine Reproductive and Respiratory Syndrome Vaccine Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Countries in 2019
Figure 60. Europe Swine Reproductive and Respiratory Syndrome Vaccine Value Market Share by Countries in 2019
Figure 61. Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Type in 2019
Figure 62. Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Application in 2019
Figure 63. Germany Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth 2015-2020 (K Units)
Figure 64. Germany Swine Reproductive and Respiratory Syndrome Vaccine Value Growth 2015-2020 ($ Millions)
Figure 65. France Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth 2015-2020 (K Units)
Figure 66. France Swine Reproductive and Respiratory Syndrome Vaccine Value Growth 2015-2020 ($ Millions)
Figure 67. UK Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth 2015-2020 (K Units)
Figure 68. UK Swine Reproductive and Respiratory Syndrome Vaccine Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth 2015-2020 (K Units)
Figure 70. Italy Swine Reproductive and Respiratory Syndrome Vaccine Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth 2015-2020 (K Units)
Figure 72. Russia Swine Reproductive and Respiratory Syndrome Vaccine Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Application in 2019
Figure 77. Egypt Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth 2015-2020 (K Units)
Figure 78. Egypt Swine Reproductive and Respiratory Syndrome Vaccine Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth 2015-2020 (K Units)
Figure 80. South Africa Swine Reproductive and Respiratory Syndrome Vaccine Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth 2015-2020 (K Units)
Figure 82. Israel Swine Reproductive and Respiratory Syndrome Vaccine Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth 2015-2020 (K Units)
Figure 84. Turkey Swine Reproductive and Respiratory Syndrome Vaccine Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth 2015-2020 (K Units)
Figure 86. GCC Countries Swine Reproductive and Respiratory Syndrome Vaccine Value Growth 2015-2020 ($ Millions)
Figure 87. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 88. Global Swine Reproductive and Respiratory Syndrome Vaccine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2021-2025 (K Units)
Figure 90. Americas Swine Reproductive and Respiratory Syndrome Vaccine Value 2021-2025 ($ Millions)
Figure 91. APAC Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2021-2025 (K Units)
Figure 92. APAC Swine Reproductive and Respiratory Syndrome Vaccine Value 2021-2025 ($ Millions)
Figure 93. Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2021-2025 (K Units)
Figure 94. Europe Swine Reproductive and Respiratory Syndrome Vaccine Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2021-2025 (K Units)
Figure 96. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Value 2021-2025 ($ Millions)
Figure 97. United States Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2021-2025 (K Units)
Figure 98. United States Swine Reproductive and Respiratory Syndrome Vaccine Value 2021-2025 ($ Millions)
Figure 99. Canada Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2021-2025 (K Units)
Figure 100. Canada Swine Reproductive and Respiratory Syndrome Vaccine Value 2021-2025 ($ Millions)
Figure 101. Mexico Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2021-2025 (K Units)
Figure 102. Mexico Swine Reproductive and Respiratory Syndrome Vaccine Value 2021-2025 ($ Millions)
Figure 103. Brazil Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2021-2025 (K Units)
Figure 104. Brazil Swine Reproductive and Respiratory Syndrome Vaccine Value 2021-2025 ($ Millions)
Figure 105. China Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2021-2025 (K Units)
Figure 106. China Swine Reproductive and Respiratory Syndrome Vaccine Value 2021-2025 ($ Millions)
Figure 107. Japan Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2021-2025 (K Units)
Figure 108. Japan Swine Reproductive and Respiratory Syndrome Vaccine Value 2021-2025 ($ Millions)
Figure 109. Korea Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2021-2025 (K Units)
Figure 110. Korea Swine Reproductive and Respiratory Syndrome Vaccine Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2021-2025 (K Units)
Figure 112. Southeast Asia Swine Reproductive and Respiratory Syndrome Vaccine Value 2021-2025 ($ Millions)
Figure 113. India Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2021-2025 (K Units)
Figure 114. India Swine Reproductive and Respiratory Syndrome Vaccine Value 2021-2025 ($ Millions)
Figure 115. Australia Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2021-2025 (K Units)
Figure 116. Australia Swine Reproductive and Respiratory Syndrome Vaccine Value 2021-2025 ($ Millions)
Figure 117. Germany Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2021-2025 (K Units)
Figure 118. Germany Swine Reproductive and Respiratory Syndrome Vaccine Value 2021-2025 ($ Millions)
Figure 119. France Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2021-2025 (K Units)
Figure 120. France Swine Reproductive and Respiratory Syndrome Vaccine Value 2021-2025 ($ Millions)
Figure 121. UK Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2021-2025 (K Units)
Figure 122. UK Swine Reproductive and Respiratory Syndrome Vaccine Value 2021-2025 ($ Millions)
Figure 123. Italy Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2021-2025 (K Units)_x000
